Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Press/Media
Datasets
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
GVHD the nuts and bolts.
Daniel Weisdorf
Medicine - Hematology, Oncology, Transplant
Transplant and Cellular Therapy
Research output
:
Contribution to journal
›
Review article
›
peer-review
43
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'GVHD the nuts and bolts.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Graft Versus Host Reaction
100%
Acute Graft Versus Host Disease
75%
Chronic Graft Versus Host Disease
50%
Tissue Injury
50%
Immune Reconstitution
25%
Infection
25%
Serositis
25%
Programmed Cell Death
25%
Allograft
25%
Prophylaxis
25%
Supportive Care
25%
T Lymphocyte
25%
Hematopoietic Stem Cell Transplantation
25%
Long Term Survival
25%
Therapeutic Management
25%
Target Cell
25%
Allogeneic Hematopoietic Stem Cell Transplantation
25%
Cytokine Release
25%
Alloimmunity
25%
Immunology and Microbiology
Graft-Versus-Host Disease
100%
Acute Graft Versus Host Disease
75%
Chronic Graft Versus Host Disease
50%
Alloimmunity
25%
Inflammation Response
25%
Immune Reconstitution
25%
Allogeneic Hematopoietic Stem Cell Transplantation
25%
Target Cell
25%
Long Term Survival
25%
Cytokine Release
25%
T Cell
25%
Hematopoietic Stem Cell Transplantation
25%
Allograft
25%
Keyphrases
Graft-versus-host Disease (GvHD)
100%
T Cells
12%
Immune Reconstitution
12%
Effective Therapy
12%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
12%
Hematopoietic Stem Cell Transplantation
12%
Supportive Care
12%
Inflammatory Response
12%
Non-relapse Mortality
12%
Disease Therapy
12%
Cell Apoptosis
12%
Long-term Survival
12%
Donor-derived
12%
Tissue Injury
12%
Allotransplantation
12%
Therapeutic Management
12%
Patient Recovery
12%
Graft-versus-host Disease Prophylaxis
12%
Cytokine Release
12%
Alloreactivity
12%
Allografting
12%
Clinical Toxicity
12%
Secondary Tissue Injury
12%
Practical Management
12%